Detalhe da pesquisa
1.
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.
Clin Exp Rheumatol
; 41(4): 864-869, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36533991
2.
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.
Clin Exp Rheumatol
; 41(4): 910-915, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36912345
3.
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Clin Exp Rheumatol
; 40(4): 727-733, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35349405
4.
The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Clin Exp Rheumatol
; 39 Suppl 129(2): 21-26, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33734973
5.
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.
Clin Exp Rheumatol
; 38 Suppl 124(2): 112-119, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32441643
6.
Tumor-induced osteomalacia: A systematic literature review.
Bone Rep
; 21: 101772, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38774264
7.
Efficacy of belimumab in Primary Sjögren's syndrome: A systematic review.
Reumatol Clin (Engl Ed)
; 17(3): 170-174, 2021 Mar.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-32451263
8.
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients.
Semin Arthritis Rheum
; 51(2): 387-394, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33607384
9.
Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review.
Ther Adv Musculoskelet Dis
; 13: 1759720X211020917, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34211589
10.
Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients. / Supervivencia a largo plazo de los fármacos biológicos anti-TNF subcutáneos administrados durante los años 2008-2012 en una cohorte de pacientes con artritis reumatoide.
Reumatol Clin (Engl Ed)
; 15(1): 54-57, 2019.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-28551175
11.
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
Semin Arthritis Rheum
; 49(1): 126-135, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30655091
12.
Efficacy of belimumab in Primary Sjögren's syndrome: A systematic review / Eficacia del belimumab en el síndrome de Sjögren primario: una revisión sistemática
Reumatol. clín. (Barc.)
; 17(3): 170-174, Mar. 2021. ilus, tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-211823
13.
Tumor-induced hypophosphatemic osteomalacia: description of 2 cases. / Osteomalacia hipofosfatémica tumoral: descripción de 2 casos.
Med Clin (Barc)
; 152(1): e3-e4, 2019 01 04.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-29776656
14.
Supervivencia a largo plazo de los fármacos biológicos anti-TNF subcutáneos administrados durante los años 2008-2012 en una cohorte de pacientes con artritis reumatoide / Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients
Reumatol. clín. (Barc.)
; 15(1): 54-57, ene.-feb. 2019. tab, graf
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-176077
15.
Facticial panniculitis and Löfgren's syndrome: a case.
Reumatol Clin
; 8(6): 368-71, 2012.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-22483663
16.
Osteomalacia hipofosfatémica tumoral: descripción de 2 casos / Tumor-induced hypophosphatemic osteomalacia: description of 2 cases
Med. clín (Ed. impr.)
; 152(1): e3-e4, ene. 2019. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-181678
17.
Paniculitis facticia y síndrome de Löfgren inducidos por silicona: a propósito de un caso clínico / Facticial panniculitis and Löfgren's syndrome: a case
Reumatol. clín. (Barc.)
; 8(6): 368-371, nov.-dic. 2012.
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-106869